Lion Point Capital LP 13D and 13G filings for Lumos Pharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-12 3:56 pm Purchase |
2020-12-31 | 13G | Lumos Pharma, Inc. LUMO |
Lion Point Capital LP | 407,192 4.900% |
407,192 (New Position) |
Filing |